A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
City of Hope Medical Center
Emory University
OHSU Knight Cancer Institute
University of Washington
Fred Hutchinson Cancer Center